P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis

Project Information

MetEpiC

Grant agreement ID: 846806

DOI

10.3030/846806

Project closed

EC signature date 10 April 2019

Start date 1 April 2020

End date 31 May 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 196 707,84

EU contribution

€ 196 707,84

Coordinated by

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome

Author(s): Emilie Montellier, Olivier Manches, Jonathan Gaucher, Claire Freycon, David Hoyos, Sandrine Blanchet, Murielle Verboom, Christina M. Dutzmann, Sophie Coutant, Jacqueline Bou, Bertrand Fin, Robert Olaso, Jean-François Deleuze, Thierry Frébourg, Benjamin D. Greenbaum, Arnold J. Levine, Christian P. Kratz, Gaëlle Bougeard, Pierre Hainaut
Published in: eBioMedicine, Issue 123, 2026, Page(s) 106065, ISSN 2352-3964
Publisher: Elsevier BV
DOI: 10.1016/j.ebiom.2025.106065

Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome

Author(s): Emilie Montellier, Nathanaël Lemonnier, Judith Penkert, Claire Freycon, Sandrine Blanchet, Amina Amadou, Florent Chuffart, Nicholas W. Fischer, Maria-Isabel Achatz, Arnold J. Levine, Catherine Goudie, David Malkin, Gaëlle Bougeard, Christian P. Kratz, Pierre Hainaut
Published in: iScience, Issue 27, 2024, Page(s) 111296, ISSN 2589-0042
Publisher: Cell Press
DOI: 10.1016/j.isci.2024.111296